Chimin Health Management Co., Ltd. Share Price

Equities

603222

CNE100002193

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
5.94 CNY +3.30% Intraday chart for Chimin Health Management Co., Ltd. +8.39% -25.84%

Financials

Sales 2022 837M 116M 9.63B Sales 2023 895M 123M 10.29B Capitalization 4.26B 587M 48.97B
Net income 2022 34M 4.69M 391M Net income 2023 -65M -8.97M -748M EV / Sales 2022 4.93 x
Net cash position 2022 49.5M 6.83M 570M Net Debt 2023 119M 16.37M 1.36B EV / Sales 2023 4.89 x
P/E ratio 2022
125 x
P/E ratio 2023
-66.8 x
Employees 1,851
Yield 2022
0.23%
Yield 2023
-
Free-Float 53.53%
More Fundamentals * Assessed data
Dynamic Chart
Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Chimin Health Management Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023. CI
Tranche Update on Chimin Health Management Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023. CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Chimin Health Management Secures Exclusive Rights to Japanese Cell Therapy Tech MT
Chimin Health Management Co., Ltd.(XSSC:603222) added to S&P Global BMI Index CI
Chimin Health Management Co., Ltd. announces an Equity Buyback for CNY 120 million worth of its shares. CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Chimin Health Management Co., Ltd. authorizes a Buyback Plan. CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Chimin Health Management Co., Ltd. announced that it has received CNY 489.999998 million in funding CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
More news
1 day+3.30%
1 week+8.39%
Current month-5.41%
1 month-8.62%
3 months-15.62%
6 months-36.27%
Current year-25.84%
More quotes
1 week
5.35
Extreme 5.35
6.11
1 month
5.34
Extreme 5.34
6.68
Current year
4.70
Extreme 4.7
8.12
1 year
4.70
Extreme 4.7
13.02
3 years
4.70
Extreme 4.7
16.28
5 years
4.70
Extreme 4.7
41.07
10 years
3.79
Extreme 3.7857
41.07
More quotes
Managers TitleAgeSince
President 44 01/08/01
Chief Tech/Sci/R&D Officer 47 15/22/15
Director/Board Member 42 11/18/11
Members of the board TitleAgeSince
Director/Board Member 67 16/19/16
Chairman 46 -
President 44 01/08/01
More insiders
Date Price Change Volume
26/24/26 5.94 +3.30% 10,905,720
25/24/25 5.75 +0.70% 6,279,240
24/24/24 5.71 +0.53% 6,699,540
23/24/23 5.68 +2.16% 6,844,700
22/24/22 5.56 +1.46% 6,704,857

End-of-day quote Shanghai S.E., April 26, 2024

More quotes
Chimin Health Management Co., Ltd., formerly Zhejiang Chimin Pharmaceutical CO., Ltd, is primarily engaged in the research, development, manufacture and sale of infusion and injection and puncture machinery products. The Company primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The Company distributes its products within domestic market and to overseas markets.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603222 Stock